Drugs / G-CSF
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02282514 Background | Oct 2014 → Aug 2019 | classic stiff person syndrome | Northwestern University | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02282514 ↗ |
| Modality | Protein / enzyme biologic | “Granulocyte-colony stimulating factor; a glycoprotein that stimulates the bone marrow to produce granulocytes and stem cells and release them into the bloodstream” NCT02282514 ↗ |
| Route | Subcutaneous | “G-CSF 5-10 mcg/kg/day subcutaneous (SQ)” NCT02282514 ↗ |